Rossari Biotech Reports 11% Revenue Growth to Rs 543.7 Crore in Q1, EBITDA Margins Decline 3 days ago
Rossari Biotech Limited reported an 11% year-on-year revenue growth to Rs 543.70 crore in Q1, driven by Home, Personal Care and Performance Chemicals (HPPC) and Animal Health and Nutrition (AHN) segments. EBITDA increased by 4.6% to Rs 67.90 crore, with a margin of 12.5%. The company faced production disruptions due to capacity expansion activities and challenges in export business. Management expects mid-double-digit growth of 14-15% for the full fiscal year and is setting up an overseas formulation facility in Southeast Asia.
Rossari Biotech Reports Mixed Q1 Results with Higher EBITDA but Lower Margins 8 days ago